Kampala, Uganda | THE INDEPENDENT | The Uganda Virus Research Institute-UVRI is set to carry out phase two human trials for the Ebola vaccine. The trials are expected to start in July. The trial is going to use the Janssen Ebola Vaccine that was developed by Janssen Pharmaceutical Company. Phase I and …
Read More »